Vantrela Er (hydrocodone Bitartrate) Cii Extended-Release Tablets Trademark Details

This mark is alive with a status of First Extension - Granted. The last case file activity for this mark occured 7 years ago on Wednesday, June 22, 2016, according to the United State Patent & Trademark Office
Word Mark Vantrela Er (Hydrocodone Bitartrate) Cii Extended-Release Tablets
Status Alive 730 — First Extension - Granted

Current Owner

Cephalon, Inc. of Salt Lake City, UT

View all trademarks for Cephalon, Inc.
Other Trademarks for Cephalon, Inc.
Serial Number 86510861
Status Date Wednesday, June 22, 2016
Filing Date Wednesday, June 22, 2016

Correspondent

HERSCHEL PEREL
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET RD
HORSHAM, PA 19044-1220

Case File Statements

Indication of Colors The color(s) dark blue, turquoise, and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text "Er Hydrocodone Bitartrate Cii, Extended-Release Tablets"
Description of Mark The mark consists of the word "VANTRELA" in the color blue, in block font, followed by 3 curved lines in the colors dark blue, turquoise, and green that overlap to form a circle with the letters "ER" in green, in block font in the center of the circle. The words "hydrocodone Bitartrate" in parenthesis in blue in block font followed by the class 2 controlled substance symbol in the color blue on the line below "VANTRELA". The words "extended-release tablets" in green in block font on the line below "hydrocodone Bitartrate".
Goods & Services Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain
Translation of Words in Mark The wording "VANTRELA" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, February 3, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.